2026 Annual Meeting and International Conference of the KSPST
December 2nd(Wed) - 4th(Fri), 2026
Songdo Convensia Premier Ballroom, Incheon, Republic of Korea
Dear KSPST Members and Participants,
On behalf of the Korean Society of Pharmaceutical Sciences and Technology (KSPST), it is my great pleasure to welcome all members, researchers, professionals, and distinguished international guests to the 2026 KSPST Annual Meeting and International Conference.
The conference will be held from December 2 to 4, 2026, at Songdo Convensia in Incheon, Korea, under the theme "Advancing Pharmaceutical Frontiers through Integrative Sciences and Innovative Technologies." This theme reflects the rapidly evolving landscape of pharmaceutical sciences and emphasizes the importance of integrating diverse scientific disciplines and innovative technologies to address emerging challenges in drug development and healthcare.
The 2026 KSPST conference has been carefully prepared to provide a comprehensive forum for sharing the latest advances in pharmaceutical research and technology. The program encompasses a broad range of topics, including biotechnology, drug delivery, advanced biopharmaceuticals, biopharmaceutics, pharmacokinetics and metabolism, polymer science, materials science, pharmaceutical manufacturing, regulatory science, and global pharmaceutical development.
This year's program features plenary lectures, KSPST award lectures, an educational session, poster presentations, and joint sessions with leading academic and professional organizations. Distinguished speakers from Korea and around the world will share their expertise and perspectives on cutting-edge topics, including next-generation drug delivery systems, mRNA and lipid nanoparticle technologies, nanomedicine, advanced biotherapeutics, translational ADME, pharmaceutical CMC, long-acting injectables, and regulatory developments. These sessions will provide valuable opportunities to explore how integrative science and innovative technologies can advance pharmaceutical research from fundamental discovery to clinical and industrial application.
We believe that this conference will serve as a meaningful platform for researchers and professionals from academia, industry, research institutes, and government to exchange ideas, share recent findings, discuss industrial and regulatory trends, and establish new collaborative relationships. In particular, the active participation of young scientists and students will further enrich the scientific exchange and contribute to the future development of pharmaceutical sciences and technology.
I would like to express my sincere appreciation to all invited speakers, session organizers, and members of the Organizing Committee whose dedication and support have made this conference possible. I hope that the 2026 KSPST Annual Meeting and International Conference will provide an inspiring and rewarding experience for everyone.
I warmly welcome you once again and sincerely wish you a successful, memorable, and enjoyable conference.
Warmest regards,
Cheong-Weon Cho, Ph.D.
President, KSPST
※ Scroll horizontally to view the full table.
| Time | Ballroom 1 | Ballroom 2 | Lobby |
|---|---|---|---|
| 18:00-20:00 | Welcome Reception (by invitation only) | ||
※ Scroll horizontally to view the full table.
| Time | Ballroom 1 | Ballroom 2 | Lobby |
|---|---|---|---|
| 09:00-10:30 | Registration | ||
| 10:30-12:00 | Annual Members’ Meeting | Educational Session View More | |
|
Yun-Seok Rhee (Gyeongsang National University, KOR) Why advanced dosage forms fail to commercialize: lessons from microneedle drug development |
|||
|
Gwan Young Kim (Daewoong Pharmaceutical Co., Ltd., KOR) From molecule to patient: industrial translation of patient-centric drug delivery platforms |
|||
|
Sang-Min Cho (Korea United Pharm. Inc., KOR) Recent trends in pharmaceutical formulation technology |
|||
| 12:00-13:00 | Lunch | ||
| 13:00-13:10 | Opening Remarks (Ballroom 1) | ||
|
Cheong-Weon Cho (President of KSPST) |
|||
| 13:10-14:00 | Plenary Lecture I (Ballroom 1)View More | ||
|
Kinam Park (Purdue University, USA) Going up with KPharma disease hunters |
|||
| 14:00-14:20 | Coffee Break | ||
| 14:20-16:05 | CRS Korea Chapter Joint Session View More | Asian Pharmaceutical Science Session View More | Poster Session I [15:00-18:00] Standing [16:00-17:00] |
| 14:20-14:55 | Yang Shi (RWTH Aachen University, Germany) Engineering immune cell processing for next-generation cancer vaccines |
Nobuhiro Nishiyama (Institute of Science Tokyo, Japan) Core-shell design of nanomedicine for targeted delivery of biopharmaceuticals |
|
| 14:55-15:30 | Alessio Malfanti (University of Padova, Italy) Exploring hyaluronic acid conjugates for the local glioblastoma immunotherapy |
Sharon Shui Yee Leung (The Chinese University of Hong Kong, Hong Kong, China) Phage-based therapeutics in the fight against drug-resistant Acinetobacter baumannii pneumonia |
|
| 15:30-16:05 | Helena F. Florindo (University of Lisbon, Portugal) Engineering the tumor microenvironment: nanomedicine-driven immune reprogramming for next-generation cancer therapies |
Yi Yan Yang (A*STAR, Singapore) Targeted mRNA delivery using functional lipid nanoparticles |
|
| 16:05-16:25 | Coffee Break | ||
| 16:25-18:10 | Biotechnology & Drug Delivery I View More | Biopharmaceutics, Pharmacokinetics & Metabolism View More | |
| 16:25-17:00 | Xiao Yu (Shirley) Wu (University of Toronto, Canada) Exploring the power of nanomaterials to break the limit of drug delivery |
Anthony J. Lee (Immunome, Inc., USA) Translational ADME in drug development |
|
| 17:00-17:35 | Mingshi Yang (University of Copenhagen, Denmark) Advancing inhaled biotherapeutics through formulation and particle engineering |
Cornelia Landersdorfer (Monash University, Australia) Integrating experimental and computational models towards innovative systems pharmacology approaches against antimicrobial resistance |
|
| 17:35-18:10 | Nathaniel S. Hwang (Seoul National University, KOR) Magnesium controls osteoimmune fracture repair |
Seung-Hyun Jeong (Sunchon National University, KOR) From aerosol aerodynamics to human pulmonary exposure: mechanistic dosimetry and cross-species translation |
|
| 18:10-20:00 | Banquet | ||
※ Scroll horizontally to view the full table.
| Time | Ballroom 1 | Ballroom 2 | Lobby |
|---|---|---|---|
| 09:00-09:30 | Registration | Poster Session II [09:00-12:00] Standing [10:00-11:00] |
|
| 09:30-10:20 | KSPST Award Lectures (Ballroom 1)View More | ||
|
Seong Hoon Jeong(Yonsei University, KOR) Ah Ram Lee(Daewon Pharmaceutical Co., Ltd., KOR) |
|||
| 10:20-12:05 | Biotechnology & Drug Delivery II View More | Global Pharma View More | |
| 10:20-10:55 | Arwyn Jones (Cardiff University, United Kingdom) Jumping into endocytic pathways to unravel the intracellular biology of LNPs and other drug delivery vectors |
Haichen Nie (Teva Pharmaceuticals, USA) Navigating cyclodextrin applications in biologics drug product development: challenges, opportunities, and formulation design strategies |
|
| 10:55-11:30 | Katrien Remaut (Ghent University, Belgium) Retinal mRNA delivery via lipid nanoparticles: particle properties and delivery challenges |
Naoki Kobayashi (Astellas Pharma Inc., Japan) Drug product CMC as integrative science: orchestrating multidisciplinary knowledge and values across the pharmaceutical lifecycle |
|
| 11:30-12:05 | Jin Woo Park(Mokpo National University, KOR) Reprogramming oral drug delivery through transporter-engineered nanoplatforms |
Hyunho Park(Breeze Bio Inc., KOR) Splenic APC-targeted mRNA delivery: a tunable hydrophilic nanoparticle platform for immune modulation |
|
| 12:05-13:15 | Lunch | ||
| 13:15-14:15 | Plenary Lecture II (Ballroom 1)View More | Poster Session III [13:15-16:15] Standing [14:15-15:15] |
|
|
Han-Gon Choi (Hanyang University, KOR) Nano-DDS screening technique for improved solubility of poorly water-soluble drugs |
|||
| 14:15-16:00 | Advanced Biopharmaceuticals View More | MFDS-KSPST Joint Session View More | |
| 14:15-14:50 | Han Chang Kang (The Catholic University of Korea, KOR) Polyester-based nanoparticles for targeting organelles or regulating cellular metabolism |
Lan Choi (National Institute of Food and Drug Safety Evaluation, KOR) Quality equivalence for synthetic peptide drugs that refer to recombinant peptides as reference listed drugs |
|
| 14:50-15:25 | Joonbeom Bae (Korea University, KOR) MSC engineering strategies for tumor-targeted immunotherapy |
Seho Kweon (Chonnam National University, KOR) Peptide-driven formulation and bioprocessing strategies for advanced biopharmaceutics |
|
| 15:25-16:00 | Jong Oh Kim (Yeungnam University, KOR) Binary mineral nanoparticles enable intravascular delivery of metal ions to tumors for metalloimmunotherapy |
Sungwon Kim (Peptron, Inc., KOR) Tailoring drug release: formulation approaches in long-acting injectables |
|
| 16:00-16:10 | Coffee Break | ||
| 16:10-17:40 | Polymer Science & Materials View More | Biotechnology & Drug Delivery III View More | |
| 16:10-16:40 | Dong Soo Hwang (Pohang University of Science and Technology, KOR) Bioinspired metabolite nanoparticle delivery |
Kang Moo Huh (Chungnam National University, KOR) Injectable glycol chitosan thermogels for advanced drug and cell delivery |
|
| 16:40-17:10 | Ji Hoon Jeong (Sungkyunkwan University, KOR) Immune modulation strategies for improved tumor control and therapy |
Jee-Heon Jeong (Sungkyunkwan University, KOR) Drug delivery-based strategies for functional enhancement of cell therapeutics |
|
| 17:10-17:40 | Heebeom Koo (The Catholic University of Korea, KOR) Biomedical application of mRNA-LNP |
Jaiwoo Lee (Korea University, KOR) Engineering drug delivery systems to overcome biological barriers and remodel pathological microenvironments |
|
| 17:40-17:50 | Poster / Presentation Award Ceremony (Ballroom 1) | ||
| 17:50-18:00 | Closing Remarks (Ballroom 1) | ||
|
Cheong-Weon Cho (President of KSPST) |
|||
※ Scroll horizontally to view the full table.
| 14:15-16:15 | Young Scientist Session and Poster Oral Presentation (Meeting Room 113) | ||
|---|---|---|---|
※ Scroll horizontally to view the full table.
| Status | Early-Bird Registration (July 27 ~ October 16, 2026) |
Advance Registration (October 17 ~ November 18, 2026) |
On-Site Registration (December 3 ~ December 4, 2026) |
Banquet Ticket |
|---|---|---|---|---|
| General Member | 220,000 KRW | 230,000 KRW | 250,000 KRW | 20,000 KRW (200 people on a first-come, first-served basis) |
| Student Member | 100,000 KRW | 110,000 KRW | 120,000 KRW | |
| Non-member | 270,000 KRW | 290,000 KRW | 320,000 KRW |
※ Scroll horizontally to view the full table.
| Membership Type | Annual Fee |
|---|---|
| Board Member | 200,000 KRW |
| Lifetime Board Member | 170,000 KRW |
| Full Member | 50,000 KRW |
| Full Member (Lifetime) | - |
| Student Member | 10,000 KRW |
※ Scroll horizontally to view the full table.
| Membership Type | Annual Fee |
|---|---|
| Council Member | 30,000 KRW |
| Council Member (Lifetime) |
※ If there is a problem with the card payment process,
※ Account information
| 100% refund | Before November 1st |
|---|---|
| No refund | After November 1st |
※ Abstract submission period: July 27th (Mon) ~ October 30th (Fri), 2026
※ Please note:

Nationals of 116 countries and regions, including the United States, Canada, the United Kingdom, most European countries, Japan, Singapore, Australia, and New Zealand, may enter the Republic of Korea without a visa for short-term visits such as attending conferences. The permitted length of stay (30 days to 6 months) varies by nationality. Please check your eligibility and permitted stay on the official K-ETA website: https://www.k-eta.go.kr
Visa and K-ETA requirements may change without notice. We strongly recommend checking with the Korea Visa Portal (https://www.visa.go.kr) or the nearest Korean embassy or consulate for the most up-to-date information.
Nationals of visa-free countries are generally required to obtain a K-ETA before boarding a flight to Korea. However, the Korean Ministry of Justice has temporarily waived the K-ETA requirement until December 31, 2026 for nationals of 22 countries and regions: the United States, Canada, the United Kingdom, Germany, France, Italy, Spain, the Netherlands, Belgium, Denmark, Sweden, Norway, Finland, Austria, Poland, Japan, Taiwan, Hong Kong, Macao, Singapore, Australia, and New Zealand. Visa-free nationals of other countries (e.g., Portugal, Switzerland, Ireland, Thailand, Malaysia, Brazil) must apply for a K-ETA at least 72 hours before departure via the official website (https://www.k-eta.go.kr) or the K-ETA mobile app. Please verify your status on the official website before traveling, as regulations may change.
In order to request the documents required for a visa application, please complete your registration and payment before requesting an official invitation letter.
Address Songdo Convensia, 123 Central Street, Yeonsu-gu, Incheon 21998, Korea
Tel +82-32-210-1114
Bus
Room 410, The Korea Science Technology Center The first building, 22, Teheran-ro 7 Gil, Gangnam-gu, Seoul 06130, Republic of Korea
Tel 02-564-4019
Fax 02-554-5378
E-mail kspst@kspst.or.kr


























